Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
UK Regulatory Position on GLP-1 Medicines and Cancer The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) maintain active surveillance of GLP-1 receptor agonists and have issued clear guidance regarding their safety profile, including cancer-related considerations
Moderate-severity concerns exist for antidiabetes drugs (ashwagandha, damiana, ginger, tribulus, and American ginseng may increase low blood sugar risk), blood pressure medications (ashwagandha, ginger, and tribulus may lower pressure too much), antibiotics like tetracyclines and quinolones (zinc may reduce their absorption), HIV drugs (zinc may reduce effectiveness of ritonavir and integrase inhibitors), and statins or other liver-metabolized drugs (niacin and ashwagandha carry hepatotoxicity risks)
Dosage for joint pain: 250-500 mcg/day subcutaneous injection near the affected joint
Sairam K, Kulinskaya E, Boustead GB, Hanbury DC, Mcnicholas TA
Your Path to Wellness: Empowering Your Health Journey Whether exploring GLP-1 agonists or committing to lifestyle changes, collaboration with your NuMed team is paramount
